The Diary Of A CEO with Steven BartlettScott Galloway: AI Wasn’t Built For You. The Rich Don’t Need You Anymore!

GLP-1 Beats AI

1:27:02–1:27:37 · 35s

In a contrarian call, Galloway says GLP-1 drugs will impact lives and create more shareholder value than AI, doubling down despite pushback.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.